Citations

Clear

16280 citation(s) found for "Yu, David".

Additional Considerations Regarding GLP-1RA Use and Thyroid Cancer Risk—Reply
Brito, Juan P. , Brito, Juan P , Toro-Tobón, David , McCoy, Rozalina G.

Mayo Clinic

JAMA Otolaryngology–Head & Neck Surgery | May 1, 2025 | Volume: 151 | Issue: 6 | Pages: 641

10.1001/jamaoto.2025.0602 | PMID 40310620 Get It

Can quantitative sensory testing predict treatment outcomes in hip and knee osteoarthritis? A systematic review and meta-analysis of individual participant data
Murphy, Myles , Mosler, A. , Coventry, Molly , Arendt‐Nielsen, Lars , Bjurström, Martin F. , Larsen, Dennis Boye , Olesen, Anne Estrup , Hertel, Emma , Holm, Pætur Mikal , Gomes, Cid André Fidelis de Paula , Drewes, Asbjørn Mohr , Nunes, Guilherme S. , Østerås, Håvard , Öztürk, Özgul , Pozsgai, M. , Rasmussen, Sten , Rice, David A. , Romero, Eleuterio A. Sánchez , Irani, Anushka, Stausholm, Martin Bjørn , Petersen, Kristian Kjær , Irani, Anushka , Murphy, Myles C , Irani, Anushka , Rio, Ebonie , Raj, Isaac Selva , Chivers, Paola , Alfieri, Fábio Marcon , Chang, Wei‐Ju , Graven‐Nielsen, Thomas , Henriksen, Marius , Klinedinst, N. Jennifer , Mathew, Jerin , O’Leary, Helen , Rampazo, Érika Patrícia , Irani, Anushka, Hince, Dana

Mayo Clinic

Pain | May 1, 2025 | Volume: 166 | Issue: 10 | Pages: 2261-2280

10.1097/j.pain.0000000000003627 | PMID 40310871 Get It

Abstract An individual participant data (IPD) meta-analysis can assess the predictive value of data on outcomes at the individual level, offering a potential tool for developing personalized pain management. Pretreatment quantitative sensory testing (QST) may stratify patient groups, which are then linked to treatment outcomes. Our objective was to determine if measures of QST at baseline are related to treatment outcomes (at any time point) for pain and disability in lower-limb osteoarthritis. We performed a systematic review with an IPD meta-analysis. Searches were conducted in 9 databases until May 5, 2023 for intervention studies that measured baseline QST and longitudinal measures of participant-reported pain and disability. We performed a 2-stage approach to analyse longitudinal data. Individual models were fitted to each study and combined using random effects multivariate meta-analytic models. Study quality was assessed using the Joanna Briggs Institute checklist, and certainty of the evidence was assessed using GRADE. We identified 3082 records and included 1 hip and 28 knee datasets consisting of 2522 participants from 40 studies. Local warm detection thresholds (P = 0.024) predicted knee osteoarthritis pain outcomes (very-low certainty). Local warm detection thresholds (P = 0.030), remote cold detection thresholds (P = 0.05), and remote pressure tolerance thresholds (P = 0.007) predicted knee osteoarthritis disability outcomes (very-low certainty). Other QST variables were associated with hip and knee osteoarthritis pain and disability levels (eg, pressure pain thresholds), but this relationship did not change over time. This review finds that mechanism-based, QST methodologies do not consistently predict pain or disability on an individual level in hip or knee osteoarthritis.
Commentary on the River Stent Trial: Venous Sinus Stenting is Safe and Effective and can be Fully Evaluated Using Noninvasive Methods
Amans, Matthew R. , Levitt, Michael R. , Hirsch, Joshua A , Mocco, J , Fiorella, David , Altschul, David , Altschul, Dorothea , Chen, Michael , Leacy, Reade De , Narsinh, Kazim , Brinjikji, Waleed , Telischak, N , Amans, Matthew , Levitt, Michael R , Mocco, J , De Leacy, Reade , Arthur, Adam Stephen , Narsinh, Kazim H , Brinjikji, Waleed , Milburn, James M , Hui, Ferdinand , Fiorella, David , Altschul, David J , Abraham, Michael G. , Hui, Ferdinand

Mayo Clinic

Journal of NeuroInterventional Surgery | April 30, 2025 | Volume: 17 | Issue: 8 | Pages: 790-791

10.1136/jnis-2025-023433 | PMID 40306927 Get It

Higher risk of recurrence in partially thrombosed cerebral aneurysms post-WEB (Woven EndoBridge) device treatment: insights from the WorldWideWEB Consortium registry
Saliou, Guillaume , Salim, Hamza , Musmar, Basel , Adeeb, Nimer , Aslan, Assala , Swaid, Christian, Cuellar, Miguel, Dibas, Mahmoud , Cancelliere, Nicole M , Diestro, Jose Danilo Bengzon , Lay, Sovann V. , Guenego, Adrien , Möhlenbruch, Markus , Kral, Michael , Salem, Mohamed M , Foreman, Paul M. , Shaikh, Hamza , Župančić, Vedran , Rabinov, James D. , Ren, Yifan , Michelozzi, Caterina , Starke, Robert M. , Ogilvie, Mark , Nguyên, Anh , Jones, Jesse , Brinjikji, Waleed , Nawka, Marie Teresa , Psychogios, Marios‐Nikos , Ulfert, Christian , Pukenas, Bryan , Burkhardt, Jan Karl, Slawski, Diana , Pulli, Benjamin , Lubicz, Boris , Puri, Ajit S , Pero, Guglielmo , Raz, Eytan , Asadi, Hamed , Siddiqui, Adnan H. , Haranhalli, Neil , Altschul, David , Ducruet, Andrew F. , Albuquerque, Felipe C , Regenhardt, Robert W. , Stapleton, Christopher J. , Kan, Peter , Kalousek, Vladimir , Lylyk, Pedro , Boddu, Srikanth , Knopman, Jared , Tjoumakaris, Stavropoula , Jabbour, Pascal , Clarençon, Frédéric , Patel, Aman B. , Salim, Hamza , Ghozy, Sherief , Lay, Sovann V , Guenego, Adrien , Carnevale, Joseph Anthony , ElNaamani, Kareem , Shotar, Eimad , Chung, Charlotte , Salem, Mohamed M , Lylyk, Ivan , Shaikh, Hamza A , Hafeez, Muhammad U , Catapano, Joshua S , Ren, Yifan , Schirmer, Clemens M , Michelozzi, Caterina , Hassan, Ameer E , Ogilvie, Mark , Nguyen, Anh , Jones, Jesse , Brinjikji, Waleed , Nawka, Marie Teresa , Huynh, Thien J, Martinez-Gutierrez, Juan Carlos , Essibayi, Muhammed Amir , Sheth, Sunil A , Tawk, Rabih G , Pulli, Benjamin , Pero, Guglielmo , Raz, Eytan , Griessenauer, Christoph J , Siddiqui, Adnan H , Levy, Elad I , Albuquerque, Felipe C , Stapleton, Christopher , Kan, Peter , Kalousek, Vladimir , Tjoumakaris, Stavropoula , Cuellar-Saenz, Hugo H , Jabbour, Pascal , Dmytriw, Adam A , Hajdu, Steven D , Dibas, Mahmoud , Diestro, Jose Danilo B , Saliou, Guillaume , Altschul, David J , Musmar, Basel , Regenhardt, Robert W , Cancelliere, Nicole M , Ulfert, Christian , Burkhardt, Jan‐Karl , Cuellar, Miguel, Algin, Oktay , Ghozy, Sherief , Renieri, Leonardo , Mastorakos, Panagiotis , Naamani, Kareem El , Shotar, Eimad , Lylyk, Iván , Hafeez, Muhammad Ubaid , Waqas, Muhammad , Arslan, Muhammet , Ergün, Onur , Schirmer, Clemens M. , Piano, Mariangela , Kühn, Anna Luisa , Hassan, Ameer E , Huynh, Thien , Essibayi, Muhammed Amir , Tawk, Rabih G. , Panni, Pietro , Griessenauer, Christoph J. , Levy, Elad I. , Cuellar, Hugo , Limbucci, Nicola , Mendes Pereira, Vitor , Dmytriw, Adam A.

Mayo Clinic

Journal of NeuroInterventional Surgery | April 30, 2025 | Volume: 18 | Issue: 3 | Pages: 782-789

10.1136/jnis-2024-022628 | PMID 40306928 Get It

Background The Woven EndoBridge (WEB) device is a prevalent treatment for intracranial aneurysms. While many studies have assessed the obliteration rate post-WEB embolization, few have focused on long-term outcomes in partially thrombosed aneurysms. Objective To assess whether partially thrombosed aneurysms are at higher risk of recurrence or retreatment following WEB embolization compared with non-thrombosed aneurysms. Methods We evaluated data from 22 academic institutions, focusing on previously untreated cerebral aneurysms treated with the WEB device. Logistic regression was utilized to analyze factors predicting long-term aneurysm obliteration and retreatment necessity. Results Among 1303 patients, 26 presented with a partially thrombosed aneurysm. In the partially thrombosed group, the mean aneurysm maximal diameter was 10.7±4 mm with a neck ratio of 1.99±1.19 mm, larger than in the control group where the mean aneurysm maximal diameter was 6.81±2.37 mm with a neck ratio of 1.64±0.51 mm (P<0.001 for both maximal diameter and neck ratio). At the final follow-up, partially thrombosed aneurysms treated by the WEB device had a 38.5% retreatment rate, compared with 7.0% for non-thrombosed aneurysms (P<0.001). Among partially thrombosed aneurysms, the Raymond-Roy type IIIa/b occlusion rate was higher (38.5% vs 9.9%, P<0.001). On multivariate analysis, partially thrombosed aneurysms compared with non-thrombosed aneurysms had an increased rate of retreatment (OR 3.64, 95% CI 1.28 to 10.1). Conclusion Partially thrombosed aneurysms are associated with a poorer occlusion rate and a higher rate of retreatment following WEB embolization. For partially thrombosed aneurysms, the WEB device appears suboptimal as a first-line treatment, and therefore alternative techniques should be prioritized.
Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
Moding, Everett J. , Esfahani, Mohammad Shahrokh , Jin, Cheng , Hui, Angela B. , Nabet, Barzin Y. , Liu, Yufei , Chabon, Jacob J. , Binkley, Michael S. , Kurtz, David M. , Hamilton, Emily G. , Chaudhuri, Aadel A. , Liu, Chih Long , Bonilla, Rene F., Jiang, Alice L. , Lau, Brianna , Lopez, Pablo , He, Jianzhong, Qiao, Yawei, Yao, Luyang , Gandhi, Saumil , Das, Millie , Ramchandran, Kavitha , Padda, Sukhmani K. , Neal, Joel W. , Wakelee, Heather A. , Li, Ruijiang , Alizadeh, Ash A. , Shahrokh Esfahani, Mohammad , Li, Zhe , Bonilla, Rene F , Jiang, Alice L , Lau, Brianna C , Lopez, Pablo , He, Jianzhong , Qiao, Yawei , Xu, Ting , Yao, Luyang , Gandhi, Saumil , Liao, Zhongxing , Das, Millie , Ramchandran, Kavitha J , Padda, Sukhmani K , Neal, Joel W , Wakelee, Heather A , Gensheimer, Michael F , Loo, Billy W , Li, Ruijiang , Lin, Steven H , Alizadeh, Ash A , Diehn, Maximillian , Binkley, Michael Sargent , Kurtz, David M , Loo, Billy W. , Lin, Steven H. , Diehn, Maximilian

Mayo Clinic

Cancer Discovery | April 29, 2025 | Volume: 15 | Issue: 8 | Pages: 1609-1629

10.1158/2159-8290.cd-24-1704 | PMID 40299851 Get It

Abstract The complementarity and clinical utility of combining liquid biopsies and radiomic image analysis has not been demonstrated. ctDNA minimal residual disease after chemoradiotherapy (CRT) for non–small cell lung cancer (NSCLC) is highly prognostic, but on-treatment biomarkers are needed to enable response-adapted therapies. In this study, we analyzed 418 patients with NSCLC undergoing CRT to develop and validate a novel dynamic risk model that accurately predicts ultimate progression-free survival during treatment. We optimize tissue-free variant calling from plasma samples to facilitate ctDNA monitoring and demonstrate the importance of accounting for persistent clonal hematopoiesis variants. We show that mid-CRT ctDNA concentration is prognostic for disease progression and integrate additional pre-CRT risk factors, including radiomics, into a combined model that improves outcome prediction. Our results suggest that tumor features, radiomics, and mid-CRT ctDNA analysis are complementary and can identify patients at high and low risk of progression to potentially enable response-adapted therapies. Significance: This study demonstrates that combining tumor features, radiomics, and ctDNA analysis improves outcome prediction in NSCLC treated with CRT therapy. Our integrated model could enable personalized and response-adapted therapies to reduce toxicity and improve outcomes in patients. See related commentary by Anagnostou and Aggarwal, p. 1534
Risk Factors for Thyroid Function Test Abnormalities During Pregnancy: A Systematic Review of the Literature to Validate Current Risk Factors and Identify Novel Ones
Liu, Yindi , Osinga, J. , Bliddal, Sofie , Alexander, Erik K. , Dosiou, Chrysoula , Boelaert, Kristien , Brenta, Gabriela , Krabbendam, Elise, Eaton, Jennifer L., Guan, Haixia , Nguyen, Caroline T. , Pearce, Elizabeth N. , Leung, Angela M. , Korevaar, Tim I.M. , Osinga, Joris A J , Bliddal, Sofie , Brenta, Gabriela , Guan, Haixia , Lee, Sun Y , Pearce, Elizabeth N , Leung, Angela M , Dosiou, Chrysoula , Maraka, Spyridoula , Morris, Lilah F. , Shan, Zhongyan , Dhillon‐Smith, Rima , Peeters, Robin P.

Mayo Clinic

Thyroid® | April 29, 2025 | Volume: 35 | Issue: 5 | Pages: 553-575

10.1089/thy.2024.0743 | PMID 40296843 Get It

Clinical characteristics and outcomes of primary orbital lymphoma
Wang, Kenny Y. , Kim, B. Michelle, Yu, Caroline , Welk, Grant M. , Churchill, Robert , White, Launia J. , Hodge, David O. , Dalvin, Lauren A. , Tooley, Andrea A. , Yu, Caroline Y, Churchill, Robert A , Dalvin, Lauren A

Mayo Clinic

European Journal of Ophthalmology | April 29, 2025 | Volume: 35 | Issue: 5 | Pages: 1776-1785

10.1177/11206721251338705 | PMID 40296647 Get It

Purpose To describe the clinical characteristics, histopathologic subtype distribution, treatment, and outcomes of patients with primary orbital lymphoma. Major Findings There were 126 biopsy-confirmed cases of primary orbital lymphoma, with 81 (64.3%) female and 110 (87.3%) white. The average age at diagnosis was 62.7 ± 13.9 years. There were 26 (20.6%) cases with bilateral involvement. The most frequent lymphoma subtype was MALT lymphoma (N = 76, 60.3%), followed by diffuse large B-cell lymphoma (N = 18, 14.3%) and follicular lymphoma (N = 12, 9.5%). Prognosis was generally favorable, as local recurrence occurred in only 14 (11.1%) patients and final best corrected visual acuity (BCVA) loss of >1 line was seen in 30 (28.0%) patients. Bilateral lymphoma and advanced stage (Ann Arbor Stage III or IV) at presentation were associated with increased risk of local recurrence ( p = 0.0025, p = 0.049). Improved disease-specific survival was associated with diagnosis at Stage I or II ( p = 0.013), MALT subtype ( p = 0.034), or lack of chemotherapy requirement as primary treatment ( p = 0.0073). Conclusions In this single center academic cohort, MALT lymphoma subtype was most common. Overall orbital recurrence frequency was low, and bilateral lymphoma and advanced stage were associated with increased risk of local recurrence. MALT lymphoma subtype was associated with improved disease-specific survival. Long-term follow-up showed that most patients retained good visual acuity in the affected eye(s).
Letter to the Editor re: Clinical Significance of Mottling Rashes in Diving Decompression Sickness
Wilmshurst, Peter , Breen, Ilana, Yale, Katerina , Swanson, David B. , Stepánek, Jan , Swanson, David, Stepánek, Jan , Marks, Lisa , Mesinkovska, Natasha Atanaskova , Swanson, David

Mayo Clinic

Aerospace Medicine and Human Performance | April 29, 2025 | Volume: 96 | Issue: 5 | Pages: 453-456

10.3357/amhp.6634.2025 | PMID 40643296 Get It

Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative
Asogwa, Ogechukwu A , Walbert, Tobias , Arons, David, Blakeley, Jaishri O. , Coomans, Marijke B , Brown, Paul D. , Bulbeck, Helen , Chang, Susan M. , Coens, Corneel , Grant, Robin, Jalali, Rakesh , Koekkoek, Johan A F , Panda, Pankaj Kumar , Leach, Danielle, Mendoza, Tito R. , Nayak, Lakshmi , Oliver, Kathy , Reijneveld, Jaap C. , Taylor, Jennie , Wen, Patrick Y. , Taphoorn, Martin , Walbert, Tobias , Blakeley, Jaishri O , Bulbeck, Helen , Gilbert, Mark R , Grant, Robin , Jalali, Rakesh , Nayak, Lakshmi , Le Rhun, Emilie , Taylor, Jennie W , Weller, Michael , Mendoza, Tito , Koekkoek, Johan A F , Dirven, Linda , Armstrong, Terri S. , Bent, Martin J. van den , Chang, Susan Marina , Gilbert, Mark R. , Leeper, Heather , Rhun, Émilie Le , Rubinstein, Larry , Wen, Patrick Yung

Mayo Clinic

Neuro-Oncology | April 28, 2025 | Volume: 27 | Issue: 9 | Pages: 2399-2414

10.1093/neuonc/noaf108 | PMID 40293144 Get It

Abstract Background Instruments to assess patient-reported outcomes (PRO) should generate high-quality evidence. Reliable PRO evidence is essential to policymakers, in conjunction with outcomes such as survival and radiological response, to understand the net clinical benefit of antitumor treatments. This study aimed to establish the content validity of 215 identified PRO measures used in patients with brain tumors. Methods A survey (n = 148 items) was developed reflecting aspects of the WHO International Classification of Functioning, Disability, and Health (ICF) framework. Patients with brain tumors, their proxies, and healthcare professionals (HCPs) were asked to rate each survey item on relevance. An item was considered a relevant issue if ≥25% of the patients or proxies or ≥50% of the HCPs considered that item to be an issue. Next, all items in the identified PRO measures were linked to ICF and relevant items in the survey, and the percentage of content coverage was calculated. Results In total, 114 patients, 71 proxies, and 65 HCPs from different countries completed the survey. Fifty-six of 148 (37.8%) items in the survey were considered relevant. The most important aspects mentioned by both patients and proxies were difficulty concentrating, difficulty remembering, multitasking, and handling stress. Depending on the definition, between 35% and 49% of PRO measures were considered to have sufficient content validity (≥80% coverage). Conclusion The content validity was insufficient in more than half of the identified PRO measures, particularly multidimensional measures. Future research should investigate whether different approaches to PRO assessment better meet the needs of all stakeholders.
Editorial: Seton Use in Perianal Fistulising Crohn's Disease. Authors' Reply
Macdonald, Blair , Rosenfeld, Greg , Bruining, David H. , Singh, Siddharth , McCurdy, Jeffrey D , Macdonald, Blair, Bessissow, Talat , Jairath, Vipul

Mayo Clinic

Alimentary Pharmacology & Therapeutics | April 28, 2025 | Volume: 61 | Issue: 12 | Pages: 1959-1960

10.1111/apt.70170 | PMID 40289278 Get It